Mycobacterium abscessus Complex Infections in Humans

New treatments, rapid and inexpensive identification methods, and measures to contain nosocomial transmission and outbreaks are urgently needed.

[1]  Meng-Rui Lee,et al.  Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: clinical features and susceptibilities of the isolates. , 2014, International journal of antimicrobial agents.

[2]  Young Kil Park,et al.  Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. , 2009, American journal of respiratory and critical care medicine.

[3]  A. Durham,et al.  Molecular Characterization of Mycobacterium massiliense and Mycobacterium bolletii in Isolates Collected from Outbreaks of Infections after Laparoscopic Surgeries and Cosmetic Procedures , 2008, Journal of Clinical Microbiology.

[4]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[5]  Young Kil Park,et al.  The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea , 2013, Annals of laboratory medicine.

[6]  R. Wallace,,et al.  Antimicrobial Susceptibility of Nontuberculous Mycobacteria From Eye Infections , 2012, Cornea.

[7]  Pan‐Chyr Yang,et al.  Increasing Incidence of Nontuberculous Mycobacteria , 2010 .

[8]  M. Raffeld,et al.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. , 2008, American journal of respiratory and critical care medicine.

[9]  Kai-Ping Chang,et al.  Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease , 2013, PloS one.

[10]  John D. Mitchell,et al.  Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  E. Picard,et al.  Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel , 2008, Emerging infectious diseases.

[12]  Pan‐Chyr Yang,et al.  Increasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008 , 2010, Emerging infectious diseases.

[13]  Enrico Tortoli,et al.  Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. , 2011, International journal of systematic and evolutionary microbiology.

[14]  N. Rao,et al.  Nontuberculous mycobacterial ocular and adnexal infections. , 2012, Survey of ophthalmology.

[15]  J. Pilewski,et al.  Epidemiology and Outcomes of Deep Surgical Site Infections Following Lung Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  Chong-Jen Yu,et al.  CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. , 2012, The Journal of antimicrobial chemotherapy.

[17]  Young Kil Park,et al.  Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. , 2011, American journal of respiratory and critical care medicine.

[18]  R. Wallace,,et al.  A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae , 2008, Antimicrobial Agents and Chemotherapy.

[19]  M. Hargreaves,et al.  Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia , 2013, BMC Microbiology.

[20]  I. Raad,et al.  Rapidly growing mycobacterial bloodstream infections. , 2013, The Lancet. Infectious diseases.

[21]  J. Parkhill,et al.  Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study , 2013, The Lancet.

[22]  M. Drancourt,et al.  Genome analysis reveals three genomospecies in Mycobacterium abscessus , 2014, BMC Genomics.

[23]  Mary Ann Blosky,et al.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. , 2010, American journal of respiratory and critical care medicine.

[24]  T. Marras,et al.  Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010 , 2013, Emerging infectious diseases.

[25]  Cheng Zhou,et al.  Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility , 2013, Chinese medical journal.

[26]  Hamed Heydari,et al.  MabsBase: A Mycobacterium abscessus Genome and Annotation Database , 2013, PloS one.

[27]  R. Wallace,,et al.  Mycobacterium abscessus: challenges in diagnosis and treatment , 2014, Current opinion in infectious diseases.

[28]  B. Gicquel,et al.  Mycobacterium abscessus: a new antibiotic nightmare. , 2012, The Journal of antimicrobial chemotherapy.

[29]  Meng-Rui Lee,et al.  Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Can Accurately Differentiate between Mycobacterium masilliense (M. abscessus subspecies bolletti) and M. abscessus (Sensu Stricto) , 2013, Journal of Clinical Microbiology.

[30]  J. Tarrand,et al.  Management of rapidly growing mycobacterial bacteremia in cancer patients. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J. Chun,et al.  The Genome Sequence of ‘Mycobacterium massiliense’ Strain CIP 108297 Suggests the Independent Taxonomic Status of the Mycobacterium abscessus Complex at the Subspecies Level , 2013, PloS one.

[32]  C. Karp,et al.  Ocular infections caused by non‐tuberculous mycobacteria: update on epidemiology and management , 2012, Clinical & experimental ophthalmology.

[33]  R. Wallace,,et al.  Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria , 2002, Clinical Microbiology Reviews.

[34]  Po-Yu Liu,et al.  Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. , 2010, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[35]  Guat Jah Wong,et al.  Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential , 2014, Scientific Reports.

[36]  F. Drobniewski,et al.  Comparative Drug Resistance of Mycobacterium abscessus and M. chelonae Isolates from Patients with and without Cystic Fibrosis in the United Kingdom , 2012, Journal of Clinical Microbiology.

[37]  K. To,et al.  Mycobacterium abscessus bacteremia after receipt of intravenous infusate of cytokine-induced killer cell therapy for body beautification and health boosting. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[39]  M. Drancourt,et al.  Mycobacterium bolletii Respiratory Infections , 2009, Emerging infectious diseases.

[40]  Guat Jah Wong,et al.  Correction: MabsBase: A Mycobacterium abscessus Genome and Annotation Database , 2013, PLoS ONE.

[41]  Kentaro Matsumoto,et al.  Multiple Cases of Cutaneous Mycobacterium massiliense Infection in a “Hot Spa” in Japan , 2010, Journal of Clinical Microbiology.

[42]  R. Wallace,,et al.  Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes , 2011 .

[43]  Smita Y. Patel,et al.  Adult-onset immunodeficiency in Thailand and Taiwan. , 2012, The New England journal of medicine.